FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ — Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded global access to high-quality, low-cost ...
A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. A planning ...
Thirteen years after the completion of the Human Genome Project, an increasing number of genomic applications including next generation sequencing (NGS) are poised for clinical use. Fulfilling the ...
FREMONT, Calif. and HOUSTON, Aug. 19, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and Gene by Gene, a leading global provider of ...
BOULDER, Colo.--(BUSINESS WIRE)--Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a ...
LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, the leading manufacturer of tissue sample preparation systems for single cell genomics assays, announced today that it has raised $16 million in Series ...
SAN DIEGO, Sept. 15, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company ...
WHO analysis finds most genomics research occurs in high-income countries, with limited LMIC participation, raising concerns ...
Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback